The North Carolina Translational & Clinical Sciences Institute has announced two awardees of the second cycle of Carolinas Collaborative grants.
Four academic institutions in North and South Carolina with Clinical and Translational Science Awards from the National Institutes of Health (Duke University, the Medical University of South Carolina, the University of North Carolina at Chapel Hill‐RTI partnership, and Wake Forest University) have partnered with the Carolinas Collaborative to encourage and facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings.
This pilot program is funded through matching contributions from the four institutions, and successful applicants have teams of investigators from at least two of the institutions.
The funded projects and teams are:
Antibiotic prescribing in North Carolina before and after an FDA boxed warning on fluoroquinolones in 2016
Deverick J. Anderson, MD, MPH
Stacie B. Dusetzina, PhD
Nicholas M. Pajewski, PhD
Wake Forest University
Zachary I. Willis, MD, MPH
Pregnancies in women with Lupus in the Carolinas Collaborative (PLiCC) Cohort: Validation of computable phenotypes with existing Registries in order to study the role of socio-demographic disparities on pregnancies in women with lupus
Megan E.B. Clowse, MD, MPH
James C. Oates, MD
Medical University of South Carolina
The Carolinas Collaborative provides a data resource (i2b2/Shrine) that harmonizes the electronic health record data elements highlighted in the CDMv3.0 across the institutions to expedite clinical research and quality improvement activities.
The Carolinas Collaborative is managed by Health Sciences South Carolina (HSSC) and funded through the Duke Endowment.